Latest Administration News

FINEOS Corporation Holdings PLC reported a seasonal decline in cash balance and customer receipts in Q4 2024, while successfully onboarding new clients and maintaining a robust North American pipeline.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

JPMorgan Asset Management has announced estimated cash distributions for its suite of equity premium income ETFs for February 2025, providing investors with key dates and payout expectations.

ADX Energy Ltd's December quarter cash flow report reveals a $1.18 million net cash decrease from operations, with $9.08 million cash on hand and ongoing financing adjustments.

Mont Royal Resources Limited reported a stable cash position of $1.75 million at the end of December 2024, despite significant outflows on exploration activities during the quarter.

E79 Gold Mines Limited reported a $169,000 net cash outflow from operating activities for the December 2024 quarter, maintaining a solid cash balance of $1.46 million as it continues its exploration efforts.

Hudson Investment Group signals potential corporate restructure as it explores sale and joint venture options for key Queensland and NSW properties.

Janus Henderson Investors has announced an estimated distribution of 22.0378 cents per unit for its Sustainable Credit Active ETF for the period ending 31 January 2025, with key dates set for early February.

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Jupiter Energy Limited reported a net operating cash inflow of $776,000 for the December 2024 quarter, maintaining a solid cash position despite heavy exploration expenditures.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.